Application of Delayed Contrast Extravasation Magnetic Resonance Imaging for Depicting Subtle Blood-Brain Barrier Disruption in a Traumatic Brain Injury Model.

MRI TBI blood-brain barrier disruption delayed contrast MRI

Journal

Journal of neurotrauma
ISSN: 1557-9042
Titre abrégé: J Neurotrauma
Pays: United States
ID NLM: 8811626

Informations de publication

Date de publication:
06 Dec 2023
Historique:
pubmed: 30 9 2023
medline: 30 9 2023
entrez: 30 9 2023
Statut: aheadofprint

Résumé

The blood-brain barrier (BBB) is composed of brain microvasculature that provides selective transport of solutes from the systemic circulation into the central nervous system to protect the brain and spinal microenvironment. Damage to the BBB in the acute phase after traumatic brain injury (TBI) is recognized as a major underlying mechanism leading to secondary long-term damage. Because of the lack of technological ability to detect subtle BBB disruption (BBBd) in the chronic phase, however, the presence of chronic BBBd is disputable. Thus, the dynamics and course of long-term BBBd post-TBI remains elusive. Thirty C57BL/6 male mice subjected to TBI using our weight drop closed head injury model and 19 naïve controls were scanned by magnetic resonance imaging (MRI) up to 540 days after injury. The BBB maps were calculated from delayed contrast extravasation MRI (DCM) with high spatial resolution and high sensitivity to subtle BBBd, enabling depiction and quantification of BBB permeability. At each time point, 2-6 animals were sacrificed and their brains were extracted, sectioned, and stained for BBB biomarkers including: blood microvessel coverage by astrocyte using GFAP, AQP4, ZO-1 gaps, and IgG leakage. We found that DCM provided depiction of subtle yet significant BBBd up to 1.5 years after TBI, with significantly higher sensitivity than standard contrast-enhanced T1-weighted and T2-weighted MRI (BBBd volumes main effect DCM/T1/T2

Identifiants

pubmed: 37776183
doi: 10.1089/neu.2023.0048
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Sigal Liraz Zaltsman (S)

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.
Department of Pharmacology, Institute for Drug Research, The Hebrew University, Jerusalem, Israel.
Institutes for Health and Medical Professions, Department of Sports Therapy, Ono Academic College, Kiryat Ono, Israel.

Shirley Sharabi (S)

The Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Israel.

David Guez (D)

The Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Israel.

Diann Daniels (D)

The Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Israel.

Itzik Cooper (I)

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.
School of Psychology, Reichman University (IDC), Herzliya, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Chen Shemesh (C)

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.

Dana Atrakchi (D)

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.

Orly Ravid (O)

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.

Liora Omesi (L)

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.

Daniel Rand (D)

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.

Abigail Livny (A)

Departments of Diagnostic Imaging and Psychiatry, Sheba Medical Center, Ramat Gan, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sagol School of Neuroscience, Tel Aviv University, Israel.

Michal Schnaider Beeri (M)

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Israel.
Department of Psychiatry, The Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Yael Friedman-Levi (Y)

Department of Pharmacology, Institute for Drug Research, The Hebrew University, Jerusalem, Israel.

Esther Shohami (E)

Department of Pharmacology, Institute for Drug Research, The Hebrew University, Jerusalem, Israel.

Yael Mardor (Y)

The Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Israel.
Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

David Last (D)

The Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Israel.

Classifications MeSH